Skip to content
Screener

Solid Biosciences Inc. SLDB Restricted Cash

Restricted Cash at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$8M0.0%
Regenxbio logo
RegenxbioRGNX
$225K—
Scholar Rock logo
Scholar RockSRRK
$3.81M+58.2%
Wave Life Sciences logo
Wave Life SciencesWVE
$3.82M+0.8%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$0-100%
Biohaven logo
BiohavenBHVN
$2.3M-27.3%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.4M-37.6%
Net income-$54.8M-38.8%
EPS (diluted)-$0.38+9.5%

Balance sheet

See full
Cash & equivalents$159.4M+14.7%
Total debt$20.2M-12.6%
Total equity$374.1M+44.8%
Total assets$420.6M+36.4%

Cash flow

See full
Operating cash flow-$52.6M-40.6%
CapEx$150.0K-60.2%
Free cash flow-$52.7M-39.6%

Valuation

See full
Market cap$917.85M+94.8%
Enterprise value$778.61M+119%

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-65.5%-2.5pp
Debt / equity0.1×0.0×
Current ratio13.8×+4.5×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-337935

FAQ

What is Solid Biosciences Inc.'s restricted cash?
Solid Biosciences Inc. (SLDB) reported restricted cash of $638K in Q2 2026.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Ask your AI about Solid Biosciences Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude